Identification of loci controlling restriction of parasite growth in experimental taenia crassiceps cysticercosis

PLoS Neglected Tropical Diseases

Volumn 5, Issue 12, 2011, Pages

  Ramirez Aquino, Ruben ^a   Radovanovic, Irena ^b   Fortin, Anny ^b   Sciutto Conde, Edda ^a   Fragoso González, Gladis ^a   Gros, Philippe ^b   Aguilar Delfin, Irma ^c  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^b MCGILL UNIVERSITY   (Canada)

^c INSTITUTO NACIONAL DE MEDICINA GENÓMICA   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ALLELE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHROMOSOME 2; CHROMOSOME 6; COMPLEMENT COMPONENT C5 GENE; CONTROLLED STUDY; GENE; GENE CONTROL; GENE FUNCTION; GENE LOCUS; GENE MAPPING; GENETIC ASSOCIATION; GENETIC IDENTIFICATION; GENETIC LINKAGE; GENOME ANALYSIS; HAPLOTYPE; HOST PARASITE INTERACTION; HOST RESISTANCE; MOUSE; NONHUMAN; PARASITE DEVELOPMENT; PARASITE LOAD; PARASITE LOCALIZATION; PHENOTYPE; SINGLE NUCLEOTIDE POLYMORPHISM; SPECIES DIFFERENCE; TAENIA CRASSICEPS; TAENIASIS; A J MOUSE; ANIMAL; C57BL MOUSE; CROSS BREEDING; CYSTICERCOSIS; DISEASE MODEL; FEMALE; GENETICS; IMMUNOLOGY; TAENIA;

COMPLEMENT COMPONENT C5;

ANIMALS; COMPLEMENT C5; CROSSES, GENETIC; CYSTICERCOSIS; DISEASE MODELS, ANIMAL; FEMALE; GENETIC ASSOCIATION STUDIES; HAPLOTYPES; MICE; MICE, INBRED A; MICE, INBRED C57BL; POLYMORPHISM, SINGLE NUCLEOTIDE; TAENIA;

EID: 84855281428     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0001435     Document Type: Article

References (49)

1. Garcia HH, Gonzalez AE, Evans CAW, Gilman RH, Cysticercosis Working Group in Peru (2003) Taenia solium cysticercosis. Lancet 362: 547-556 doi:10.1016/S0140-6736(03)14117-7.
2. Sciutto E, Fragoso G, Fleury A, Laclette JP, Sotelo J, et al. (2000) Taenia solium disease in humans and pigs: an ancient parasitosis disease rooted in developing countries and emerging as a major health problem of global dimensions. Microbes Infect 2: 1875-1890.
3. Fleury A, Morales J, Bobes RJ, Dumas M, Yánez O, et al. (2006) An epidemiological study of familial neurocysticercosis in an endemic Mexican community. Trans R Soc Trop Med Hyg 100: 551-558 doi:10.1016/j.trstmh.2005.08.008.
4. Del Brutto OH, Granados G, Talamas O, Sotelo J, Gorodezky C, (1991) Genetic pattern of the HLA system: HLA A, B, C, DR, and DQ antigens in Mexican patients with parenchymal brain cysticercosis. Hum Biol 63: 85-93.
5. Huerta M, Sciutto E, García G, Villalobos N, Hernández M, et al. (2000) Vaccination against Taenia solium cysticercosis in underfed rustic pigs of México: roles of age, genetic background and antibody response. Vet Parasitol 90: 209-219.
6. Heldwein K, Biedermann H-G, Hamperl W-D, Bretzel G, Löscher T, et al. (2006) Subcutaneous Taenia crassiceps infection in a patient with non-Hodgkin's lymphoma. Am J Trop Med Hyg 75: 108-111.
7. Freeman R, (1962) Studies on the biology of Taenia crassiceps (Zeder, 1800) Rudolphi, 1810 (Cestoda). Canadian Journal of Zoology 40: 969-990.
8. Dorais FJ, Esch GW, (1969) Growth rate of two Taenia crassiceps strains. Exp Parasitol 25: 395-398.
9. Willms K, Zurabian R, (2010) Taenia crassiceps: in vivo and in vitro models. Parasitology 137: 335-346 doi:10.1017/S0031182009991442.
10. Sciutto E, Fragoso G, Trueba L, Lemus D, Montoya RM, et al. (1990) Cysticercosis vaccine: cross protecting immunity with T. solium antigens against experimental murine T. crassiceps cysticercosis. Parasite Immunol 12: 687-696.
11. Sciutto E, Fragoso G, Diaz ML, Valdez F, Montoya RM, et al. (1991) Murine Taenia crassiceps cysticercosis: H-2 complex and sex influence on susceptibility. Parasitol Res 77: 243-246.
12. Fragoso G, Lamoyi E, Mellor A, Lomelí C, Hernández M, et al. (1998) Increased resistance to Taenia crassiceps murine cysticercosis in Qa-2 transgenic mice. Infection and Immunity 66: 760-764.
13. Meneses G, Berzunza M, Becker I, Bobes RJ, Rosas G, et al. (2009) Taenia crassiceps cysticercosis: variations in its parasite growth permissiveness that encounter with local immune features in BALB/c substrains. Exp Parasitol 123: 362-368 doi:10.1016/j.exppara.2009.09.002.
14. Reyes JL, Terrazas CA, Vera-Arias L, Terrazas LI, (2009) Differential response of antigen presenting cells from susceptible and resistant strains of mice to Taenia crassiceps infection. Infect Genet Evol 9: 1115-1127 doi:10.1016/j.meegid.2009.05.011.
15. Fragoso G, Lamoyi E, Mellor A, Lomelí C, Govezensky T, et al. (1996) Genetic control of susceptibility to Taenia crassiceps cysticercosis. Parasitology 112 (Pt 1): 119-124.
16. Fragoso G, Meneses G, Sciutto E, Fleury A, Larralde C, (2008) Preferential growth of Taenia crassiceps cysticerci in female mice holds across several laboratory mice strains and parasite lines. J Parasitol 94: 551-553 doi:10.1645/GE-1287.1.
17. Vargas-Villavicencio JA, Larralde C, De León-Nava MA, Escobedo G, Morales-Montor J, (2007) Tamoxifen treatment induces protection in murine cysticercosis. J Parasitol 93: 1512-1517 doi:10.1645/GE-1191.1.
18. Ibarra-Coronado EG, Escobedo G, Nava-Castro K, Jesús Ramses C-R, Hernández-Bello R, et al. (2011) A helminth cestode parasite express an estrogen-binding protein resembling a classic nuclear estrogen receptor. Steroids 76: 1149-1159 doi:10.1016/j.steroids.2011.05.003.
19. Fortin A, Diez E, Rochefort D, Laroche L, Malo D, et al. (2001) Recombinant congenic strains derived from A/J and C57BL/6J: a tool for genetic dissection of complex traits. Genomics 74: 21-35 doi:10.1006/geno.2001.6528.
20. Sciutto E, Fragoso G, Baca M, la Cruz De V, Lemus L, et al. (1995) Depressed T-cell proliferation associated with susceptibility to experimental Taenia crassiceps infection. Infection and Immunity 63: 2277-2281.
21. Tuite A, Elias M, Picard S, Mullick A, Gros P, (2005) Genetic control of susceptibility to Candida albicans in susceptible A/J and resistant C57BL/6J mice. Genes Immun 6: 672-682 doi:10.1038/sj.gene.6364254.
22. Wetsel RA, Fleischer DT, Haviland DL, (1990) Deficiency of the murine fifth complement component (C5). A 2-base pair gene deletion in a 5′-exon. J Biol Chem 265: 2435-2440.
23. Haley CS, Knott SA, (1992) A simple regression method for mapping quantitative trait loci in line crosses using flanking markers. Heredity 69: 315-324.
24. Broman KW, Wu H, Sen S, Churchill GA, (2003) R/qtl: QTL mapping in experimental crosses. Bioinformatics 19: 889-890.
25. Kang HM, Zaitlen NA, Wade CM, Kirby A, Heckerman D, et al. (2008) Efficient Control of Population Structure in Model Organism Association Mapping. Genetics 178: 1709-1723 doi:10.1534/genetics.107.080101.
26. Min-Oo G, Fortin A, Pitari G, Tam M, Stevenson MM, et al. (2007) Complex genetic control of susceptibility to malaria: positional cloning of the Char9 locus. J Exp Med 204: 511-524 doi:10.1084/jem.20061252.
27. Fortin A, Diez E, Henderson JE, Mogil JS, Gros P, et al. (2007) The AcB/BcA recombinant congenic strains of mice: strategies for phenotype dissection, mapping and cloning of quantitative trait genes. Novartis Found Symp 281: 141-53; discussion 153-5, 208-9.
28. Meunier C, Cai J, Fortin A, Kwan T, Marquis J-F, et al. (2010) Characterization of a major colon cancer susceptibility locus (Ccs3) on mouse chromosome 3. Oncogene 29: 647-661 doi:10.1038/onc.2009.369.
29. Roy MF, Riendeau N, Loredo-Osti JC, Malo D, (2006) Complexity in the host response to Salmonella Typhimurium infection in AcB and BcA recombinant congenic strains. Genes Immun 7: 655-666 doi:10.1038/sj.gene.6364344.
30. Radovanovic I, Mullick A, Gros P, (2011) Genetic Control of Susceptibility to Infection with Candida albicans in Mice. PLoS ONE 6: e18957 doi:10.1371/journal.pone.0018957.
31. Lambris JD, Ricklin D, Geisbrecht BV, (2008) Complement evasion by human pathogens. Nat Rev Microbiol 6: 132-142 doi:10.1038/nrmicro1824.
32. Zipfel PF, (2009) Complement and immune defense: from innate immunity to human diseases. Immunol Lett 126: 1-7 doi:10.1016/j.imlet.2009.07.005.
33. Ooi YM, Colten HR, (1979) Genetic defect in secretion of complement C5 in mice. Nature 282: 207-208.
34. Siebert AE, Good AH, Simmons JE, (1978) Ultrastructural aspects of early immune damage to Taenia crassiceps metacestodes. Int J Parasitol 8: 45-53.
35. Davis SW, Hammerberg B, (1988) Activation of the alternative pathway of complement by larval Taenia taeniaeformis in resistant and susceptible strains of mice. Int J Parasitol 18: 591-597.
36. Letonja T, Hammerberg B, (1983) Third component of complement, immunoglobulin deposition, and leucocyte attachment related to surface sulfate on larval Taenia taeniaeformis. J Parasitol 69: 637-644.
37. Ferreira AM, Breijo M, Sim RB, Nieto A, (2000) Contribution of C5-mediated mechanisms to host defence against Echinococcus granulosus hydatid infection. Parasite Immunol 22: 445-453.
38. Terrazas LI, Bojalil R, Govezensky T, Larralde C, (1998) Shift from an early protective Th1-type immune response to a late permissive Th2-type response in murine cysticercosis (Taenia crassiceps). J Parasitol 84: 74-81.
39. Terrazas LI, Cruz M, Rodríguez-Sosa M, Bojalil R, García-Tamayo F, et al. (1999) Th1-type cytokines improve resistance to murine cysticercosis caused by Taenia crassiceps. Parasitol Res 85: 135-141.
40. Toenjes SA, Kuhn RE, (2003) The initial immune response during experimental cysticercosis is of the mixed Th1/Th2 type. Parasitol Res 89: 407-413 doi:10.1007/s00436-002-0788-z.
41. Chavarria A, Roger B, Fragoso G, Tapia G, Fleury A, et al. (2003) TH2 profile in asymptomatic Taenia solium human neurocysticercosis. Microbes Infect 5: 1109-1115.
42. Restrepo BI, Alvarez JI, Castaño JA, Arias LF, Restrepo M, et al. (2001) Brain granulomas in neurocysticercosis patients are associated with a Th1 and Th2 profile. Infection and Immunity 69: 4554-4560 doi:10.1128/IAI.69.7.4554-4560.2001.
43. Mullick A, Elias M, Picard S, Bourget L, Jovcevski O, et al. (2004) Dysregulated inflammatory response to Candida albicans in a C5-deficient mouse strain. Infection and Immunity 72: 5868-5876 doi:10.1128/IAI.72.10.5868-5876.2004.
44. Maccallum DM, Castillo L, Brown AJP, Gow NAR, Odds FC, (2009) Early-Expressed Chemokines Predict Kidney Immunopathology in Experimental Disseminated Candida albicans Infections. PLoS ONE 4: e6420 doi:10.1371/journal.pone.0006420.t005.
45. Balish E, Wagner RD, Vazquez-Torres A, Pierson C, Warner T, (1998) Candidiasis in interferon-gamma knockout (IFN-gamma-/-) mice. J Infect Dis 178: 478-487.
46. Laclette JP, Shoemaker CB, Richter D, Arcos L, Pante N, et al. (1992) Paramyosin inhibits complement C1. J Immunol 148: 124-128.
47. Rodriguez-Sosa M, David JR, Bojalil R, Satoskar AR, Terrazas LI, (2002) Cutting edge: susceptibility to the larval stage of the helminth parasite Taenia crassiceps is mediated by Th2 response induced via STAT6 signaling. J Immunol 168: 3135-3139.
48. Rodriguez-Sosa M, Saavedra R, Tenorio EP, Rosas LE, Satoskar AR, et al. (2004) A STAT4-dependent Th1 response is required for resistance to the helminth parasite Taenia crassiceps. Infection and Immunity 72: 4552-4560 doi:10.1128/IAI.72.8.4552-4560.2004.
49. Alonso-Trujillo J, Rivera-Montoya I, Rodriguez-Sosa M, Terrazas LI, (2007) Nitric oxide contributes to host resistance against experimental Taenia crassiceps cysticercosis. Parasitol Res 100: 1341-1350 doi:10.1007/s00436-006-0424-4.